Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection.
Jim Cramer Says China’s Vaccines ‘Don’t Work’ But Xi Won’t Admit It
COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
“Health And Human Services Report Says Mask Mandates Should Be Reinstated To Help ‘Long Covid'” – NYPost
Not this again.
Masks and social distancing should be mandated or encouraged in public to protect people from possible “long COVID”, a new Department of Health and Human Services report
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% – Plus 4 New Holdings For Ark
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Moderna Stock Is Surging Today: What’s Going On?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday after the company announced its bivalent Omicron-targeting booster candidates showed a superior antibody response compared to a booster dose of its
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
Moderna Inc (NASDAQ:MRNA) said that data shows its omicron-tailored vaccines, mRNA-1273.214 and mRNA-1273.222, produced a higher antibody response against…
The Bear Market Could Go On For Longer If History Proves Right, But 1 Sector Is Bucking The Downturn
The S&P 500 is showing a recovery in November, but experts think it’s still too early to tell if October’s lows were this cycle’s rough bottom: the situation hasn’t improved enough to consider the equity markets